Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin

International Journal of Antimicrobial Agents

Volumn 38, Issue 6, 2011, Pages 538-539

  Arends, Joop E ^a   Fransen, Justin H ^a   Hoepelman, Andy I M ^a   Van Baarle, Debbie ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hepatitis C; IL28B; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON ALPHA2B PLUS RIBAVIRIN;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; POLYETHYLENE GLYCOLS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 80255123281     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.08.010     Document Type: Article

References (15)

1. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558 567 (Pubitemid 41196755)
2. N.H. Afdhal The natural history of hepatitis C Semin Liver Dis 24 Suppl. 2 2004 3 8 (Pubitemid 39180700)
3. J.G. McHutchison, E.J. Lawitz, M.L. Shiffman, A.J. Muir, G.W. Galler, and J. McCone Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 2009 580 593
4. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
5. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
6. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, I.J. Di, and T. Mueller Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345
7. T.M. Scherzer, H. Hofer, A.F. Staettermayer, K. Rutter, S. Beinhardt, and P. Steindl-Munda Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin J Hepatol 54 2011 866 871
8. A.J. Thompson, A.J. Muir, M.S. Sulkowski, D. Ge, J. Fellay, and K.V. Shianna Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 2010 120 129
9. P.Y. Bochud, S. Bibert, F. Negro, B. Haagmans, A. Soulier, and C. Ferrari IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C J Hepatol 2011 [Epub ahead of print]
10. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107 (Pubitemid 28471138)
11. F.C. Bekkering, J.T. Brouwer, S.W. Schalm, and A. Elewaut Hepatitis C: viral kinetics Hepatology 26 1997 1691 1693
12. J.E. Arends, J.C. Stuart, L.C. Baak, M.E. van der Ende, K.J. van Erpecum, and C.P. Simons Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at Week 4 of peginterferon-alfa-2a/ribavirin therapy J Viral Hepat 16 2009 867 875
13. E.S. de Araujo, H. Dahari, S.J. Cotler, T.J. Layden, A.U. Neumann, and C.E. Melo Pharmacodynamics of PEG-IFN-α-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients J Acquir Immune Defic Syndr 56 2011 95 99
14. M. Honda, A. Sakai, T. Yamashita, Y. Nakamoto, E. Mizukoshi, and Y. Sakai Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
15. M. Sarasin-Filipowicz, E.J. Oakeley, F.H. Duong, V. Christen, L. Terracciano, and W. Filipowicz Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci USA 105 2008 7034 7039 (Pubitemid 351754525)